Agreed. The issue is that when working 1:1 you get a feel for how many tokens are being burned but the subagent spawn could be 3 or in one cases it spawned 171 to verify something. The latter was unexpected and burned through my token budget.
For coding Opus 4.8 with ultracode is near perfect and doesn't grind away as many tokens. Fable is advertised as 2x the tokens but in my experience it is closer to 5x what I burn with Opus 4.8.
For coding I'm finding the same thing. It does appear better when I'm doing research. But 4.8 with ultracode is very competent at 99% of tasks I throw at it.
The US is still dominant for research spending and high impact scientific publications and medicine. I too would be interested in where they think it would be better. Israel and South Korea are the only two that might provide more opportunities depending on the area of interest.
It's more like once you figure out how to make a really good lamp then producing lots of lamps will be profitable. But the lamps are currently suboptimal so we'll be in the red until that time.
This comment reads as if it were dropped into a generic "genetics of lifespan" thread,. The Dynomight article is already making a much more sophisticated version of some of these same points. The article's central argument is precisely that heritability is a contingent observational statistic, not a Platonic form. This particular article isn't conflating heritability with genetic mechanism at all. It's interrogating a simulation model and its assumptions. The warning about "unqualified instruments" and "retrospective observational data" feels off as this paper isn't a straightforward observational study. it's a parametric simulation fitted to twin registry data.
This comment might be very useful in a Reddit thread full of people saying "50% of lifespan is in your DNA," but it's a bit off-target as a response to this particular article.
That and we can observe how certain policies play out. I used to be a big decriminalize drugs guy but watching it play out in a few states has had me rethink that idea. I haven't done a 180 or anything but it is something I'd be more cautious about implementing.
I pay cash for a medication because the insurance won't pay for the 90 day supply and it's a hassle to deal with it every month. It's $70 for me to pay for 90 days out of pocket versus paying a $20 deductible each month. I'm only paying $10 extra to avoid the hassle. Worth it.
It appears you're using a Vanguard total market fund. Nothing wrong with that, it's clearly broader than the SP500, but I suspect more folks are familiar with the latter. In that spirit folks might be interested to know it's not much different. If Tesla disappeared tomorrow with would be 2.4% of the SP500.